We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial (FAB24)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01551264
Recruitment Status : Active, not recruiting
First Posted : March 12, 2012
Last Update Posted : January 30, 2018
Sponsor:
Collaborator:
Shriners Hospitals for Children
Information provided by (Responsible Party):
Washington University School of Medicine

Brief Summary:
Prolonged bracing reduces the rate of clubfoot recurrence. In addition to bracing length, other factors, including compliance with bracing, gender, age, severity of clubfoot deformity and family history contribute to clubfoot recurrence.

Condition or disease Intervention/treatment
Isolated Clubfoot Device: Foot Abduction Brace (FAB)

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 124 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trail
Study Start Date : May 2012
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : March 2019

Arm Intervention/treatment
4-Year Bracing Arm
This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method.
Device: Foot Abduction Brace (FAB)
After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in.
2-Year Bracing Arm
This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method.
Device: Foot Abduction Brace (FAB)
After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in.



Primary Outcome Measures :
  1. Establish the time dependent risk for relapse with need for further therapy in isolated clubfoot for 2 year versus 4 year bracing [ Time Frame: 1 year after bracing discontinued ]

Secondary Outcome Measures :
  1. Determine whether covariates that include compliance with bracing, gender, age, severity, and family history are associated with relapse [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 1 Year   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject < 1 year of age when treatment initiated at local site
  • Confirmed diagnosis of Isolated Clubfoot
  • At least one foot demonstrates fixation of the foot in equinus, forefoot adduction, cavus and hindfoot varus
  • Deformity was present at birth

Exclusion Criteria:

  • Previous foot abduction bracing
  • Previous surgical correction (excluding Tenotomy)
  • Dysmorphic features, additional anomalies (i.e. congenital heart disease, hypospadias, a genetic syndrome), or developmental delay
  • Neurologic cause for clubfoot (i.e. myelomeningocele or sacral agenesis)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01551264


Locations
United States, California
Shriners Hospital for Children
Sacramento, California, United States, 95817
United States, Florida
Nemours Children's Hospital
Orlando, Florida, United States, 32827
United States, Kentucky
Shriners Hospital for Children
Lexington, Kentucky, United States, 40502
United States, Missouri
Washington University School of Medicine
Saint Louis, Missouri, United States, 63110
Shriners Hospital for Children
Saint Louis, Missouri, United States, 63131
United States, Oregon
Shriners Hospital for Children
Portland, Oregon, United States, 97239
United States, Washington
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Sponsors and Collaborators
Washington University School of Medicine
Shriners Hospitals for Children
Investigators
Principal Investigator: Matthew B Dobbs, MD Washington University School of Medicine

Responsible Party: Washington University School of Medicine
ClinicalTrials.gov Identifier: NCT01551264     History of Changes
Other Study ID Numbers: 201110158
First Posted: March 12, 2012    Key Record Dates
Last Update Posted: January 30, 2018
Last Verified: January 2018

Additional relevant MeSH terms:
Clubfoot
Talipes
Equinus Deformity
Foot Deformities, Acquired
Foot Deformities
Musculoskeletal Diseases
Foot Deformities, Congenital
Lower Extremity Deformities, Congenital
Limb Deformities, Congenital
Musculoskeletal Abnormalities
Congenital Abnormalities